Method for inhibiting stemness of pancreatic cancer stem cells with miR-200a
A mir-200a, pancreatic cancer stem cell technology, applied in the direction of tumor/cancer cells, animal cells, vertebrate cells, etc., can solve the problems of ease of operation, cost, and unsatisfactory effect, and achieve low cost, convenient operation, and effect. Good results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028] A method for miR-200a inhibiting stemness characteristics of pancreatic cancer stem cells, comprising the following steps:
[0029] A) Human pancreatic cancer cell line PANC-1 culture
[0030] DMEM culture medium containing 10% fetal bovine serum (FBS) was used as the medium, at 37°C, 5% CO 2 The human pancreatic cancer cell line PANC-1 was cultured under saturated humidity conditions, passaged once every 2-3 days, and digested with 0.25% trypsin every passage;
[0031] B) Detection and sorting of pancreatic cancer stem cells by flow cytometry
[0032] (1) Digest PANC-1 cancer cells into single cell suspension
[0033] After the cells grow to the logarithmic growth phase, remove the culture medium, wash once with PBS, add 0.25% trypsin, and digest at 37°C for 5 minutes; DMEM culture medium), pipette several times; transfer to a sterile centrifuge tube, centrifuge at 1000r / min for 5min, resuspend cells in PBS, and count on a hemocytometer;
[0034] (2) Antibody Incuba
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap